Top

Reactions Weekly

Published in:

01-05-2024 | Pyrazinamide | Case report

Isoniazid/pyrazinamide

Acute generalised exanthematous pustulosis

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Moubine I, et al. Acute generalized exanthematous pustulosis induced by isoniazid and pyrazinamide in a child. Revue Francaise d'Allergologie 63: 1-3, No. 7, Nov 2023. Available from: URL: 10.1016/j.reval.2023.103727

Title: Isoniazid/pyrazinamide
Acute generalised exanthematous pustulosis
Publication date: 01-05-2024
Publisher: Springer International Publishing
Keywords: Pyrazinamide
Isoniazid
Ethambutol
Rifampicin
Tuberculosis
Tuberculosis
Neutrophilia
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-58244-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Isoniazid/pyrazinamide

Acute generalised exanthematous pustulosis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Aripiprazole

Cefotaxime/metronidazole/praziquantel

Non-serious case reports

Welgenaleucel

Isoniazid

Abiraterone-acetate/prednisone